Added to YB: 2024-09-25
Pitch date: 2024-09-25
AQST [bullish]
Aquestive Therapeutics, Inc.
-20.16%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Aquestive Therapeutics, Inc. operates as a pharmaceutical company in the United States and internationally.
Market Cap
$445.3M
Pitch Price
$4.96
Price Target
N/A
Dividend
N/A
EV/EBITDA
-6.70
P/E
-5.25
EV/Sales
8.24
Sector
Pharmaceuticals
Category
growth
Show full summary:
Aquestive Therapeutics’ Anaphylm: Revolutionizing Anaphylaxis Care with Multi-Billion Dollar Potential
AQST: Anaphylm for severe allergies/anaphylaxis could generate $1-1.5B/yr. High demand in schools, hospitals, venues, transport. Longer shelf life possible but not desired by company to ensure refills. Broad market potential across various sectors.
Read full article (1 min)